The role of cAMP in ovulation, oocyte maturation and prostaglandin production was assessed using a rabbit ovary 
Introduction
During the growth of the mammalian ovarian follicle, gona¬ dotrophin stimulation initiates a cascade of events including steroidogenesis and resumption of oocyte meiosis, leading to rupture of the follicle and release of a mature ovum (for reviews, see Thibault, 1977; Richards, 1980; Espey, 1980; Yoshimura and Wallach, 1987 (Richards, 1980; Dekel and Beers, 1980; Amsterdam et ah, 1981;  Knecht and Catt, 1982; Boynton and Whitfield, 1983) . Forskolin, an activator of adenylyl cyclase, induces ovulation in vitro in the absence of gonadotrophin (Holmes et ah, 1986) , implying that cAMP production by the preovulatory follicle may be sufficient to initiate the ovula¬ tory process. Ryan and Coronel (1969) (Kubasik et ah, 1984) . The interassay and intra-assay coefficients of variation were 6.8% and 2.3%, respectively.
The concentrations of PGF2a, PGE2, prostacyclin (PGI2) and thromboxane B2 (TXB2) released into the perfusate were measured by the methods described by Dubin et ah (1979, 1982 (Fig. 3) .
The concentration of 6-keto PGFIa in the perfusate of ovaries treated with the three concentrations of dibutyryl cAMP was determined 12 h after hCG administration (Fig. 4) . Forskolin has been reported to induce ovulation in the absence of gonadotrophin by others using a similar rabbit ovary system perfused in vitro (Holmes et ah, 1986) . Obser¬ vations supporting this finding have also been made in a rat ovary perfusion system (Brannström et ah, 1987 Clark, 1982) . Although circumstantial evidence has been provided for the involvement of PGI2 in the process of ovulation, the instability of this compound has limited any experimentation designed to investigate its role in ovarian physiology (Dusting et ah, 1978) . We demonstrated that PGI2 methyl ester, with its longer half-life (2.7 h at pH 7.4), induces ovulation in vitro in the absence of gonadotrophin (Yoshimura et ah, 1988) . Furthermore, the vascular changes in PGI2-treated ovaries parallel those observed when ovaries are exposed to gonadotrophin both in situ and in vitro (Kitai et ah, 1985;  
